NCT07453394 2026-03-06QLS5132 Combination Therapy in Advanced Solid TumorsQilu Pharmaceutical Co., Ltd.Phase 1/2 Not yet recruiting626 enrolled
NCT07272590 2025-12-09Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid TumorsQilu Pharmaceutical Co., Ltd.Phase 1/2 Not yet recruiting290 enrolled